This Study Will Evaluate the Safety, Tolerability, Activity of the Drug in the Body and Effectiveness of Baloxavir Marboxil Given as Granules in a Single Dose to Otherwise Healthy Children with Influenza - Trial 2021-001026-22
Access comprehensive clinical trial information for 2021-001026-22 through Pure Global AI's free database. This phase not specified trial is sponsored by Shionogi & Co., Ltd. and is currently status unknown. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2021-001026-22
Trial Details
EU Clinical Trials Register • 2021-001026-22
This Study Will Evaluate the Safety, Tolerability, Activity of the Drug in the Body and Effectiveness of Baloxavir Marboxil Given as Granules in a Single Dose to Otherwise Healthy Children with Influenza
Study Focus
Sponsor & Location
Shionogi & Co., Ltd.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Time to alleviation of influenza illness
ICD-10 Classifications
Influenza and pneumonia
Influenza due to identified seasonal influenza virus
Influenza with other manifestations, seasonal influenza virus identified
Influenza with pneumonia, seasonal influenza virus identified
Influenza due to identified zoonotic or pandemic influenza virus
Data Source
EU Clinical Trials Register
2021-001026-22
Non-Device Trial